Cargando…
Iron Bisglycinate Chelate and Polymaltose Iron for the Treatment of Iron Deficiency Anemia: A Pilot Randomized Trial
BACKGROUND: Iron Deficiency Anemia (IDA) is a major public health problem worldwide. Iron Bisglycinate Chelate (FeBC) and polymaltose iron (FeP) are used for the treatment of IDA and exhibit good tolerability with a low incidence of adverse effects. However, these compounds have important difference...
Autores principales: | Name, José João, Vasconcelos, Andrea Rodrigues, Maluf, Maria Cristina Valzachi Rocha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416187/ https://www.ncbi.nlm.nih.gov/pubmed/30280670 http://dx.doi.org/10.2174/1573396314666181002170040 |
Ejemplares similares
-
Efficacy of Supplementation with Iron Sulfate Compared to Iron
Bisglycinate Chelate in Preterm Infants
por: Bagna, Rossana, et al.
Publicado: (2018) -
Effectiveness of iron polymaltose complex in treatment and prevention of iron deficiency anemia in children: a systematic review and meta-analysis
por: Mohd Rosli, Ritzzaleena Rosli, et al.
Publicado: (2021) -
Efficacy, Tolerability, and Acceptability of Iron Hydroxide Polymaltose Complex versus Ferrous Sulfate: A Randomized Trial in Pediatric Patients with Iron Deficiency Anemia
por: Yasa, Beril, et al.
Publicado: (2011) -
Effect of treatment with single total-dose intravenous iron versus daily oral iron(III)-hydroxide polymaltose on moderate puerperal iron-deficiency anemia
por: Iyoke, Chukwuemeka Anthony, et al.
Publicado: (2017) -
Zein Beta-Cyclodextrin Micropowders for Iron Bisglycinate Delivery
por: Esposito, Diletta, et al.
Publicado: (2020)